On the trail of fugitive fat: the chase turns to NRTIs.
Mascolini
M
M
D000818:Animals; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000494:pharmacology; D002318:Cardiovascular Diseases / Q000209:etiology; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control; D008928:Mitochondria / Q000187:drug effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D013997:Time Factors
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors